The research is funded by the Oslo University Hospital (OUS), the South-Eastern Norway Regional Health Authority, and the Research Council of Norway. Nina Iversen (OUS) is an associated member of the group, and we have several central collaborators both nationally and internationally in addition to cooperating with other groups at the RIIM and OUS.
The influence of rivaroxaban on markers of fibrinolysis and endothelial cell activation/injury in patients with venous thrombosis
Thromb Res, 177, 154-156
Transcription factor FOXP3: A repressor of the TFPI gene?
J Cell Biochem (in press)
Relationship between sex hormone binding globulin and blood coagulation in women on postmenopausal hormone treatment
Blood Coagul Fibrinolysis, 30 (1), 17-23